This post a few days ago refers to the impact of Asian sourcing on both large traditional homecare manufacturers and the smaller “importer” – fast brand developing companies in Europe and in Germany in particular.
The announcement (see Reuters article) today of the Yuan revaluation is probably going to remove a point or two of margin from both company types as the customer downstream is still not willing to accept a price increase.
Few, if any homecare companies are making a lot of money in Germany. This does not help.
The writer is going to be in Shanghai next week. It will be interesting to hear the Chinese perspective. More to come…
About Frank Barlin
Frank is the founder and managing partner at Sibaya. He provides recognized leadership in homecare consulting and has advised firms ranging in size from those listed on the NYSE and the LSE to early stage startups.
Frank’s international experience is broad-based, having spent his professional life based in Europe, the United States and South Africa. Prior to founding Sibaya in 2002 he was European Vice President for a publicly traded healthcare company.
In addition he has held various country general management positions and directorships. Recent home healthcare projects include European business development, acquisition strategy and advice, competitive benchmarking, Asian outsourcing and turnaround management. He works out of the Paris office.
